| Use of a vaginal ring containing dapivirine for HIV-1 prevention in women JM Baeten, T Palanee-Phillips, ER Brown, K Schwartz, LE Soto-Torres, ... New England Journal of Medicine 375 (22), 2121-2132, 2016 | 859 | 2016 |
| Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study JM Baeten, T Palanee-Phillips, NM Mgodi, AJ Mayo, DW Szydlo, ... The lancet HIV 8 (2), e87-e95, 2021 | 79 | 2021 |
| Noninferiority of a task-shifting HIV care and treatment model using peer counselors and nurses among Ugandan women initiated on ART: evidence from a randomized trial FM Kiweewa, D Wabwire, J Nakibuuka, M Mubiru, D Bagenda, P Musoke, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 63 (4), e125-e132, 2013 | 66 | 2013 |
| Bone mineral density changes among young, healthy African women receiving oral tenofovir for HIV preexposure prophylaxis BG Mirembe, CW Kelly, N Mgodi, S Greenspan, JY Dai, A Mayo, J Piper, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (3), 287-294, 2016 | 62 | 2016 |
| Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial ER Brown, CW Hendrix, A van der Straten, FM Kiweewa, NM Mgodi, ... Journal of the International AIDS Society 23 (11), e25634, 2020 | 58 | 2020 |
| Impact of male partner involvement on women’s adherence to the dapivirine vaginal ring during a phase III HIV prevention trial ST Roberts, G Nair, JM Baeten, T Palanee-Philips, K Schwartz, K Reddy, ... AIDS and Behavior 24, 1432-1442, 2020 | 42 | 2020 |
| Elevated risk of bacterial vaginosis among users of the copper intrauterine device: a prospective longitudinal cohort study K Peebles, FM Kiweewa, T Palanee-Phillips, C Chappell, D Singh, ... Clinical Infectious Diseases 73 (3), 513-520, 2021 | 34 | 2021 |
| “The number of clients is increasing but the supplies are reducing”: provider strategies for responding to chronic antiretroviral (ARV) medicines stock-outs in resource-limited … H Zakumumpa, FM Kiweewa, F Khuluza, FE Kitutu BMC health services research 19, 1-11, 2019 | 34 | 2019 |
| Characteristics of women enrolled into a randomized clinical trial of dapivirine vaginal ring for HIV-1 prevention T Palanee-Phillips, K Schwartz, ER Brown, V Govender, N Mgodi, ... PloS one 10 (6), e0128857, 2015 | 34 | 2015 |
| Acquisition of sexually transmitted infections among women using a variety of contraceptive options: a prospective study among high‐risk African women FM Kiweewa, E Brown, A Mishra, G Nair, T Palanee‐Phillips, N Mgodi, ... Journal of the International AIDS Society 22 (2), e25257, 2019 | 21 | 2019 |
| Vaginal ring use in a phase 3 microbicide trial: a comparison of objective measures and self-reports of non-adherence in ASPIRE BS Mensch, BA Richardson, M Husnik, ER Brown, FM Kiweewa, AJ Mayo, ... AIDS and behavior 23, 504-512, 2019 | 18 | 2019 |
| A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study,“the Nevirapine Repeat … FM Kiweewa, PM Bakaki, MS McConnell, M Musisi, C Namirembe, ... BMC Public Health 15, 1-7, 2015 | 17 | 2015 |
| Implementation of a novel adherence monitoring strategy in a phase III, blinded, placebo-controlled, HIV-1 prevention clinical trial MJ Husnik, ER Brown, M Marzinke, E Livant, T Palanee-Phillips, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (3), 330-337, 2017 | 16 | 2017 |
| Brief report: dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception JE Balkus, T Palanee-Phillips, K Reddy, S Siva, I Harkoo, C Nakabiito, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (2), e47-e51, 2017 | 15 | 2017 |
| Factors associated with willingness to use oral pre-exposure prophylaxis (PrEP) in a fisher-folk community in peri-urban Kampala, Uganda B Ssuna, A Katahoire, M Armstrong-Hough, D Kalibbala, JN Kalyango, ... BMC public health 22 (1), 468, 2022 | 13 | 2022 |
| Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study M Garcia, E Luecke, AJ Mayo, R Scheckter, P Ndase, FM Kiweewa, ... BMC Public Health 21, 1-11, 2021 | 7 | 2021 |
| Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women … FK Matovu, N Kiwanuka, M Nabwana, D Scholes, P Musoke, MG Fowler, ... The Lancet Global Health 10 (5), e694-e704, 2022 | 6 | 2022 |
| Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda H Musana, JT Ssensamba, M Nakafeero, H Mugerwa, FM Kiweewa, ... AIDS Research and Therapy 18, 1-10, 2021 | 6 | 2021 |
| Correlates of adherence to the dapivirine vaginal ring for HIV-1 prevention MJ Husnik, ER Brown, SS Dadabhai, Z Gaffoor, N Jeenarain, ... AIDS and Behavior 25 (9), 2801-2814, 2021 | 6 | 2021 |
| Community health workers improve HIV disclosure among HIV-affected sexual partners in rural Uganda: a quasi-experimental study Z Lukyamuzi, RM Nabisere, R Nakalega, P Atuhaire, H Kataike, B Ssuna, ... Global Health: Science and Practice 10 (5), 2022 | 5 | 2022 |
